Add to ORKGAbrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA)
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on rel...
The potential for multi-criteria decision analysis (MCDA) to support health technology assessment (H...
This short comment argues that both cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA...
Daniels, Porteny and Urrutia et al make a good case for the idea that that public decisions ought to...
The article by Daniels and colleagues on expanding the scope of health technology assessment (HTA) t...
This brief commentary seeks to develop the analysis of Daniels, Porteny and Urrutia of the implicati...
All societies face the need to make judgments about what interventions (both public health and perso...
This comment refers to the article available at https://doi.org/10.1007/s40258-018-0373-y
Cost-effectiveness analysis (CEA) plays a key role informing decision-making in healthcare and, cons...
Plain Language Summary Health Technology Assessment (HTA) is an evidence-based decisi...
This document is the accepted manuscript version of the following article: Nicola Allen, Stuart R. W...
The article by Daniels and colleagues on expanding the scope of health technology assessment (HTA) t...
textabstractEmbedding health technology assessment (HTA) in a fair process has great potential to ca...
In the editorial published in this journal, Daniels and colleagues argue that his and Sabin’s accoun...
Background: Although value issues are increasingly addressed in health technology assessment (HTA) r...
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on rel...
The potential for multi-criteria decision analysis (MCDA) to support health technology assessment (H...
This short comment argues that both cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA...
Daniels, Porteny and Urrutia et al make a good case for the idea that that public decisions ought to...
The article by Daniels and colleagues on expanding the scope of health technology assessment (HTA) t...
This brief commentary seeks to develop the analysis of Daniels, Porteny and Urrutia of the implicati...
All societies face the need to make judgments about what interventions (both public health and perso...
This comment refers to the article available at https://doi.org/10.1007/s40258-018-0373-y
Cost-effectiveness analysis (CEA) plays a key role informing decision-making in healthcare and, cons...
Plain Language Summary Health Technology Assessment (HTA) is an evidence-based decisi...
This document is the accepted manuscript version of the following article: Nicola Allen, Stuart R. W...
The article by Daniels and colleagues on expanding the scope of health technology assessment (HTA) t...
textabstractEmbedding health technology assessment (HTA) in a fair process has great potential to ca...
In the editorial published in this journal, Daniels and colleagues argue that his and Sabin’s accoun...
Background: Although value issues are increasingly addressed in health technology assessment (HTA) r...
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on rel...
The potential for multi-criteria decision analysis (MCDA) to support health technology assessment (H...
This short comment argues that both cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA...